Skip to content

Evaluating the feasibility and acceptability of a time limited anxiety in bipolar disorder

A randomised controlled trial evaluating the feasibility and acceptability of a time limited anxiety intervention in bipolar disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN84288072
Enrollment
72
Registered
2011-03-28
Start date
2011-01-05
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar disorder Mental and Behavioural Disorders Anxiety in patients with bipolar disorder

Interventions

1. PARADES Anxiety, A psychological intervention for the joint treatment of anxiety and bipolar disorder 2. Follow Up Length: 20 month(s)
Study Entry : Single Randomisation only 3. Participants who take part in this study will be randomly allocated to receive either the intervention, or their usual treatment.

Sponsors

Lancaster University (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Primary diagnosis of bipolar I or II disorder 2. Current experience of anxiety evidenced by a HADS-A score > 8 3. Aged 18+ 4. Ability to understand spoken and written English to a level where participants are able to provide written informed consent and are able to participate in interviews, questionnaires and therapy sessions, where appropriate. 5. Male or Female

Exclusion criteria

Exclusion criteria: 1. Current experience of a manic, hypomanic, depressed or mixed episode, or experience of this in the past four weeks, although it is expected that some subsyndromal symptoms will be present 2. Current suicidal ideation with intent

Design outcomes

Primary

MeasureTime frame
Recruitment & Retention: Timepoint(s): Baseline, 4, 8, 12, 16 and 20 months

Secondary

MeasureTime frame
Anxiety symptoms; Timepoint(s): Baseline, 4, 8, 12 16 and 20 months; Mood symptoms; Timepoint(s): Baseline, 4, 8, 12, 16 and 20 months.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 23, 2026